Metsera Inc

NEW
NAS:MTSR (USA)  
$ 23.65 +1.97 (+9.09%) 03:50 PM EST
At Loss
Volume:
719.05K
Avg Vol (2M):
973.13K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
719.05K
At Loss
Avg Vol (2M):
973.13K

Business Description

Description
Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementing proprietary methods and platform technologies to advance a broad, scalable, and combinable portfolio of injectable and oral NuSH analog peptides with the potential to address not only the limitations of approved therapies but also many of the anticipated limitations of next-generation therapies in development. The Company uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization half-life extending platform.
Name Current Vs Industry Vs History
Cash-To-Debt 35.96
Equity-to-Asset 0.64
Debt-to-Equity 0.03
Debt-to-EBITDA -0.07
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 79.02
9-Day RSI 62.79
14-Day RSI 55.35

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.34
Quick Ratio 5.34
Cash Ratio 5.24

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROE % -30.76
ROA % -17.49
ROIC % -33.3
ROC (Joel Greenblatt) % -25945.79
ROCE % -53.2

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -18.72
EV-to-EBITDA -18.73
EV-to-FCF -186.03
Price-to-Net-Cash 12.89
Earnings Yield (Greenblatt) % -5.34
FCF Yield % -0.54

Financials (Next Earnings Date:2025-05-30 Est.)

MTSR's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:MTSR

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Metsera Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.513
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % -
14-Day RSI 55.35
14-Day ATR ($) 2.810838
20-Day SMA ($) 20.435
12-1 Month Momentum % -
52-Week Range ($) 12.3 - 32.8082
Shares Outstanding (Mil) 105.05

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Metsera Inc Filings

Filing Date Document Date Form
No Filing Data

Metsera Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Metsera Inc Frequently Asked Questions

What is Metsera Inc(MTSR)'s stock price today?
The current price of MTSR is $23.65. The 52 week high of MTSR is $32.81 and 52 week low is $12.30.
When is next earnings date of Metsera Inc(MTSR)?
The next earnings date of Metsera Inc(MTSR) is 2025-05-30 Est..
Does Metsera Inc(MTSR) pay dividends? If so, how much?
Metsera Inc(MTSR) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1